CDT Equity

CDTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.109 M

$0.15 -11.49%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$39.2M

Loss-making

Shares outstanding

6,310,778

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

CDT Equity lists more than one class of stock. Company figures above cover all classes combined.

CDTTW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#493Artelo BiosciencesARTL$2.25M
#494Propanc BiopharmaPPCB$2.21M
#495CDT EquityCDT$2.11M
#496Clearmind MedicineCMND$1.70M
#497Decoy TherapeuticsDCOY$1.68M

What if CDT Equity were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,210,775

Per share 14,355,683× higher

Bitcoin $1.72T

$125,589.37

Per share 815,515× higher

Nvidia $5.48T

$400,168.87

Per share 2,598,499× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for CDT Equity are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.